Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00138125
Status:
TERMINATED
Last Update Posted:
2020-10-19
First Post:
2005-08-29
Brief Title:
Fulvestrant andor Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Cancer
Sponsor:
Translational Oncology Research International
Organization:
Translational Oncology Research International
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-04
Start Date Type:
None
Primary Completion Date:
2009-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-12
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-29
First Submit QC Date:
August 29 2005
Study First Post Date:
2005-08-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2013-02-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-24
Last Update Post Date:
2020-10-19
Last Update Post Date Type:
ACTUAL